TMO
TMO
Market read
TMO's better-than-expected earnings and revenue reflect operational strength in life sciences and diagnostics segments, directly relevant to investors tracking healthcare technology and biotech equipment suppliers.
Try Pro
Track capital flows and market sentiment in real time, across every asset.
@financialjuice · 07/23, 05:01 PM
Market reactionThermo Fisher reported Q2 adjusted EPS of $6.03 and revenue of $11.99B, both exceeding consensus estimates.
TMO's better-than-expected earnings and revenue reflect operational strength in life sciences and diagnostics segments, directly relevant to investors tracking healthcare technology and biotech equipment suppliers.
Related markets